Bevazizumab reduces neurocan content and gene expression in newborn rat retina in vitro (2014)
Source: Investigative ophthalmology & visual science. Unidade: FM
Subjects: EXPRESSÃO GÊNICA, PROTEOGLICANAS, ADERÊNCIA CELULAR, RETINA (PATOLOGIA), RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KREMPEL, Paloma G. et al. Bevazizumab reduces neurocan content and gene expression in newborn rat retina in vitro. Investigative ophthalmology & visual science, v. 55, p. 5109-5115, 2014Tradução . . Disponível em: https://doi.org/10.1167/iovs.14-14466. Acesso em: 15 nov. 2024.APA
Krempel, P. G., Matsuda, M., Marquezini, M. V., Seixas, T. G., Ventura, G. M., Sholl-Franco, A., et al. (2014). Bevazizumab reduces neurocan content and gene expression in newborn rat retina in vitro. Investigative ophthalmology & visual science, 55, 5109-5115. doi:10.1167/iovs.14-14466NLM
Krempel PG, Matsuda M, Marquezini MV, Seixas TG, Ventura GM, Sholl-Franco A, Miguel NCO, Monteiro MLR. Bevazizumab reduces neurocan content and gene expression in newborn rat retina in vitro [Internet]. Investigative ophthalmology & visual science. 2014 ; 55 5109-5115.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1167/iovs.14-14466Vancouver
Krempel PG, Matsuda M, Marquezini MV, Seixas TG, Ventura GM, Sholl-Franco A, Miguel NCO, Monteiro MLR. Bevazizumab reduces neurocan content and gene expression in newborn rat retina in vitro [Internet]. Investigative ophthalmology & visual science. 2014 ; 55 5109-5115.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1167/iovs.14-14466